Please assess the completion status of the following clinical trial:

Trial Title: Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients must meet DSM-IV criteria for Major Depressive Disorder.~* Patients must have severe depression.~* MADRS greater than or equal to 30~Exclusion Criteria:~* Women who are pregnant, women who will be breastfeeding during the study, and women of childbearing potential who are not practicing a reliable method of birth control.~* Patients who are considered a suicide risk.~* Patients who currently meet DSM-IV criteria for: a principal diagnosis for Axis I disorder other than MDD (comorbid GAD is allowed), bipolar disorder, schizophrenia or any psychotic disorder, obsessive-compulsive disorder, dysthymia.~* Patients with a family history of bipolar disorder, schizophrenia, or any psychotic disorder.~* Patients with history of any psychotic disorder or any psychotic feature.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).